ENTEROCUTANEOUS FISTULA side effect
What is ENTEROCUTANEOUS FISTULA ?Drugs associated with ENTEROCUTANEOUS FISTULA
BUSULFAN CETUXIMAB HUMIRA PROGRAF REMICADE SULPERAZON SUTENT TOPOTECANENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5633442-7
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Feb 12, 2008. Male patient, weighting 158.7 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SUTENT dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, VITAMIN B, HYDROCODONE BITARTRATE, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5596554-2
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Male patient, weighting 159.0 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SUTENT dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, VITAMIN B, HYDROCODONE BITARTRATE, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Topotecan Side Effects Report #5532058-0
Physician from GERMANY reported TOPOTECAN problem on Nov 26, 2007. Female patient, 41 years of age, weighting 337.3 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, faecal incontinence, . TOPOTECAN dosage: 3.5MG SEE TEXT. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Cetuximab Side Effects Report #5537110-1
CETUXIMAB problem was reported by a Health Professional from UNITED STATES on Dec 05, 2007. Male patient, weighting 150.0 lb, was diagnosed with colon cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, peau d'orange, procedural site reaction, refusal of treatment by patient, thrombocytopenia, . CETUXIMAB dosage: unknown. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5542860-7
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Nov 29, 2007. Male patient, weighting 159.0 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SUTENT dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, VITAMIN B, HYDROCODONE BITARTRATE, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5564110-8
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2007. Male patient was diagnosed with malignant neoplasm of ampulla of vater and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SUTENT dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, VITAMIN B, HYDROCODONE BITARTRATE, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5572751-7
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Dec 12, 2007. Male patient, weighting 159.0 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SUTENT dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, VITAMIN B, HYDROCODONE BITARTRATE, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Topotecan Side Effects Report #5505329-1
TOPOTECAN problem was reported by a Physician from GERMANY on Oct 26, 2007. Female patient, 41 years of age, weighting 337.3 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . TOPOTECAN dosage: unknown. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Topotecan Side Effects Report #5512908-4
Physician from GERMANY reported TOPOTECAN problem on Nov 06, 2007. Female patient, 41 years of age, weighting 337.3 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . TOPOTECAN dosage: 3.5MG SEE TEXT. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5525900-0
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2007. Male patient, weighting 159.0 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SUTENT dosage: unknown. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, LISINOPRIL, VITAMIN B, HYDROCODONE BITARTRATE, FERROUS SULPHATE, DOCUSATE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sulperazon Side Effects Report #5500902-9
Physician from JAPAN reported SULPERAZON problem on Oct 22, 2007. Female patient was diagnosed with colon cancer metastatic and was treated with SULPERAZON. After drug was administered, patient experienced the following problems/side effects: enterocutaneous fistula, . SULPERAZON dosage: unknown. During the same period patient was treated with JUZENTAIHOTO, LENDORMIN, FAMOTIDINE, FLUOROURACIL, OXALIPLATIN, CALCIUM LEVOFOLINATE, BEVACIZUMAB. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sulperazon Side Effects Report #5645570-0
SULPERAZON problem was reported by a Physician from JAPAN on Feb 22, 2008. Female patient was diagnosed with colon cancer metastatic and was treated with SULPERAZON. After drug was administered, patient experienced the following problems/side effects: disease progression, enterocutaneous fistula, . SULPERAZON dosage: unknown. During the same period patient was treated with JUZENTAIHOTO, LENDORMIN, GASTER, VOLTAREN, FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN. Patient died on 11/29/2007.
ENTEROCUTANEOUS FISTULA : Sulperazon Side Effects Report #5542477-4
Physician from JAPAN reported SULPERAZON problem on Dec 06, 2007. Female patient was diagnosed with colon cancer metastatic and was treated with SULPERAZON. After drug was administered, patient experienced the following problems/side effects: disease progression, enterocutaneous fistula, . SULPERAZON dosage: unknown. During the same period patient was treated with JUZENTAIHOTO, LENDORMIN, FAMOTIDINE, VOLTAREN, FLUOROURACIL, BEVACIZUMAB, OXALIPLATIN. Patient died on 11/29/2007.
ENTEROCUTANEOUS FISTULA : Cetuximab Side Effects Report #5544569-2
CETUXIMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2007. Male patient, 65 years of age, weighting 149.9 lb, was diagnosed with colon cancer metastatic and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: cellulitis, enterocutaneous fistula, thrombocytopenia, . CETUXIMAB dosage: unknown. During the same period patient was treated with OXALIPLATIN, CAPECITABINE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Sutent Side Effects Report #5565458-3
Physician from ARGENTINA reported SUTENT problem on Dec 06, 2007. Female patient, 52 years of age, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: duodenal fistula, enterocutaneous fistula, . SUTENT dosage: unknown. Patient was hospitalized. Patient died on 11/01/2007.
ENTEROCUTANEOUS FISTULA : Remicade Side Effects Report #5506260-8
REMICADE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2007. Female patient, weighting 122.0 lb, was diagnosed with crohn's disease, infection and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, enterocutaneous fistula, ischaemic cardiomyopathy, malignant hypertension, multi-organ failure, myocardial infarction, pulmonary oedema, renal artery stenosis, renal failure acute, . REMICADE dosage: unknown. During the same period patient was treated with FLAGYL. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Busulfan Side Effects Report #5408208-3
Consumer or non-health professional from UNITED STATES reported BUSULFAN problem on Aug 06, 2007. Female patient, weighting 127.9 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, enterocutaneous fistula, febrile neutropenia, metabolic disorder, sepsis, stem cell transplant, . BUSULFAN dosage: 640 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died on 07/14/2007.
ENTEROCUTANEOUS FISTULA : Humira Side Effects Report #5620492-X
HUMIRA problem was reported by a Consumer or non-health professional from GERMANY on Jan 31, 2008. Male patient, weighting 196.2 lb, was diagnosed with ankylosing spondylitis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: abscess, dental caries, enterocutaneous fistula, . HUMIRA dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Prograf Side Effects Report #5630306-X
Physician from UNITED STATES reported PROGRAF problem on Feb 04, 2008. Male patient, 15 years of age, was diagnosed with liver and small intestine transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bacteraemia, disease recurrence, enterocutaneous fistula, feeding tube complication, gastroenteritis norovirus, gastrointestinal stoma complication, pneumonia, urinary tract infection, . PROGRAF dosage: unknown. Patient was hospitalized. Patient recovered.
ENTEROCUTANEOUS FISTULA : Prograf Side Effects Report #5644257-8
PROGRAF problem was reported by a Physician from UNITED STATES on Feb 19, 2008. Female patient, 59 years of age, weighting 95.02 lb, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: apnoea, breath sounds absent, enterocutaneous fistula, fall, immunosuppression, infection, lung transplant rejection, pupil fixed, respiratory distress, . PROGRAF dosage: 1 MG, UID/QD, ORAL. During the same period patient was treated with AZATHIOPRINE, CIPRO, PERCOCET, LEXAPRO, AVAPRO, CYPROHEPTADINE, MEGACE, PREDNISOLONE ACETATE. Patient died on 02/18/2006.
ENTEROCUTANEOUS FISTULA : Topotecan Side Effects Report #5579187-3
Physician from GERMANY reported TOPOTECAN problem on Dec 24, 2007. Female patient, 41 years of age, weighting 337.3 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal wall abscess, enterococcal bacteraemia, enterocutaneous fistula, faecal incontinence, postoperative wound infection, pyrexia, . TOPOTECAN dosage: 3.5MG SEE TEXT. During the same period patient was treated with PACLITAXEL. Patient was hospitalized. Patient recovered.